|
1
|
Treatment of CNS relapse in children with acute lymphoblastic leukemia: A Pediatric Oncology Group study.
|
J Clin Oncol
|
1993
|
1.45
|
|
2
|
Radiotherapy (2500 rad) for testicular leukemia: local control and subsequent clinical events: a Southwest Oncology Group study.
|
Cancer
|
1980
|
1.42
|
|
3
|
Extended triple intrathecal chemotherapy trial for prevention of CNS relapse in good-risk and poor-risk patients with B-progenitor acute lymphoblastic leukemia: a Pediatric Oncology Group study.
|
J Clin Oncol
|
1993
|
1.36
|
|
4
|
Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study.
|
Leukemia
|
1999
|
1.14
|
|
5
|
Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma.
|
Cancer
|
1989
|
1.08
|
|
6
|
Leukemic cell growth in SCID mice as a predictor of relapse in high-risk B-lineage acute lymphoblastic leukemia.
|
Blood
|
1995
|
1.03
|
|
7
|
Philadelphia chromosome and monosomy 7 in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study.
|
Blood
|
1991
|
0.89
|
|
8
|
Growth in children with acute lymphocytic leukemia: a Pediatric Oncology Group study.
|
Med Pediatr Oncol
|
1983
|
0.86
|
|
9
|
Growth factor practice patterns among pediatric oncologists: results of a 1998 Pediatric Oncology Group Survey. Economic Evaluation Working Group the Pediatric Oncology Group.
|
J Pediatr Hematol Oncol
|
2000
|
0.78
|
|
10
|
Ifosfamide with mesna uroprotection and etoposide in recurrent, refractory acute leukemia in childhood. A Pediatric Oncology Group Study.
|
Cancer
|
1993
|
0.78
|
|
11
|
Favorable prognosis associated with hyperdiploidy in children with acute lymphocytic leukemia correlates with extra chromosome 6. A Pediatric Oncology Group study.
|
Cancer
|
1990
|
0.77
|
|
12
|
Therapy of refractory or recurrent childhood acute myeloid leukemia using amsacrine and etoposide with or without azacitidine: a Pediatric Oncology Group randomized phase II study.
|
J Clin Oncol
|
1996
|
0.75
|
|
13
|
A phase I trial of fazarabine in refractory pediatric solid tumors. A Pediatric Oncology Group study.
|
Invest New Drugs
|
1993
|
0.75
|
|
14
|
The non-random dic(9;12) translocation in acute lymphoblastic leukemia is associated with B-progenitor phenotype and an excellent prognosis.
|
Leukemia
|
1992
|
0.75
|
|
15
|
Transitional pre-B-cell acute lymphoblastic leukemia of childhood is associated with favorable prognostic clinical features and an excellent outcome: a Pediatric Oncology Group study.
|
Leukemia
|
1993
|
0.75
|
|
16
|
Phase I trial of continuous infusion carboplatin and etoposide in children with refractory acute leukemia: a Pediatric Oncology Group study.
|
J Clin Oncol
|
1994
|
0.75
|
|
17
|
Circulating immune complexes in childhood malignancies: a Pediatric Oncology Group study.
|
J Clin Oncol
|
1983
|
0.75
|
|
18
|
Low response rate to 5 aza-cytidine, vincristine, and prednisone therapy in previously treated childhood acute nonlymphocytic leukemia: a Southwest Oncology Group Study.
|
Am J Pediatr Hematol Oncol
|
1981
|
0.75
|